BNGO - Bionano Genomics, Inc.
1.21
0 0%
Share volume: 93,093
Last Updated: 04-24-2026
Measuring And Control Equipment/Lab Analytical Instruments:
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$1.21
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-14-2024 | 05-14-2025 | 08-14-2025 | 11-13-2025 | 03-23-2026 | |
| Total revenue | 8.769 M | 7.771 M | 6.073 M | 6.457 M | 6.733 M | 7.367 M | 7.951 M | |
| Cost of revenue | 5.945 M | 5.186 M | 14.519 M | 3.519 M | 3.256 M | 3.997 M | 4.551 M | |
| Gross profit | 2.824 M | 2.585 M | -8.446 M | 2.938 M | 3.477 M | 3.370 M | 3.400 M | |
| -8.46% | -426.73% | 134.79% | 18.35% | -3.08% | 0.89% | |||
| Operating expenses | 29.315 M | 18.388 M | 14.181 M | 11.403 M | 11.277 M | 11.908 M | 11.936 M | |
| Selling general and admin | 19.536 M | 11.557 M | 9.464 M | 9.033 M | 8.346 M | 9.064 M | 8.707 M | |
| Research and development | 9.779 M | 6.831 M | 4.717 M | 2.370 M | 2.931 M | 2.844 M | 3.229 M | |
| Total expenses | 33.947 M | 19.603 M | 35.455 M | 11.403 M | 11.277 M | 11.908 M | 11.936 M | |
| -42.25% | 80.87% | -67.84% | -1.10% | 5.60% | 0.24% | |||
| Operating income | -31.123 M | -17.018 M | -43.901 M | -8.465 M | -7.800 M | -8.538 M | -8.536 M | |
| Ebit | -32.362 M | -16.655 M | -44.598 M | -3.385 M | -7.124 M | -8.757 M | -8.173 M | |
| Pretax income | -31.440 M | -16.198 M | -44.222 M | -3.095 M | -6.847 M | -8.489 M | -7.897 M | |
| -48.48% | 173.01% | -93.00% | 121.23% | 23.98% | -6.97% | |||
| Income tax | -18.000 K | 26.000 K | 24.000 K | 7.000 K | 10.000 K | 14.000 K | 36.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -31.422 M | -16.224 M | -44.246 M | -3.102 M | -6.857 M | -8.503 M | -7.933 M | |
| 48.37% | -172.72% | 92.99% | -121.05% | -24.00% | 6.70% |